The Influence of Performance Status, Inflammation, and Nutrition on the Impact of SGLT2 Inhibitors on Cancer Outcomes

Documenti analoghi

• Myxedema Coma as a Presentation of Panhypopituitarism Secondary to Traumatic Brain Injury
  di: Diego Rivas-Otero, et al.
  Pubblicazione: (2024)
• Hypoalbuminemia and Nutritional Status in Children With Cancer
  di: Thomas W. McLean, et al.
  Pubblicazione: (2024)
• Nutritional Status of Women Diagnosed With Breast Cancer
  di: Heba M. Zahid, et al.
  Pubblicazione: (2025)
• Tumor‐Bearing Status Accelerates Bleomycin‐Induced Pulmonary Inflammation via Endothelial Activation
  di: Shoko Isoyama, et al.
  Pubblicazione: (2026)
• Real‐World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient‐Specific Factors Influencing Survival and Response Rate
  di: Lena Huber, et al.
  Pubblicazione: (2025)